Literature DB >> 9553765

The enigmatic role of glutamyl aminopeptidase (BP-1/6C3 antigen) in immune system development.

J Wang1, Q Lin, Q Wu, M D Cooper.   

Abstract

The murine B-lymphocyte differentiation antigen BP-1/6C3, a homodimeric integral membrane protein composed of M, 140,000 subunits, has been identified as glutamyl aminopeptidase (EAP, EC 3.4.11.7). This ecto-enzyme cleaves acidic amino acid residues from the amino terminal of polypeptide substrates such as angiotensin II and cholecystokinin-8. Although BP-1/6C3/EAP is expressed by cells in many tissues, among hematopoietic cell lineages this ecto-enzyme is restricted to immature B-lineage cells where its expression is upregulated by interleukin-7 and viral transformation. BP-1/6C3/EAP thus serves as a valuable marker of progression along the B-cell differentiation pathway, but a corresponding biological role has not yet been established.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9553765     DOI: 10.1111/j.1600-065x.1998.tb01572.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  4 in total

1.  The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells.

Authors:  A Dinkel; K Warnatz; B Ledermann; A Rolink; P F Zipfel; K Bürki; H Eibel
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

Review 2.  Ectopeptidases in pathophysiology.

Authors:  C Antczak; I De Meester; B Bauvois
Journal:  Bioessays       Date:  2001-03       Impact factor: 4.345

3.  ENPEP as a potential predictor of immune checkpoint inhibitor efficacy.

Authors:  Aoyun Wang; Han Chu; Zheng Jin; Zhihua Gong; Qingzhu Jia; Bo Zhu
Journal:  Cancer Med       Date:  2021-12-03       Impact factor: 4.452

4.  Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177.

Authors:  Anton Amadeus Hörmann; Maximilian Klingler; Maliheh Rezaeianpour; Nikolas Hörmann; Ronald Gust; Soraya Shahhosseini; Elisabeth von Guggenberg
Journal:  Molecules       Date:  2020-10-08       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.